{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:57:08Z","timestamp":1764935828036},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.prp.2017.06.017","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T19:01:31Z","timestamp":1498676491000},"page":"1166-1172","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential"],"prefix":"10.1016","volume":"213","author":[{"given":"Juan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2017.06.017_bib0005","first-page":"318","article-title":"Acute myeloid leukemia: biologic prognostic, and therapeutic insights","volume":"30","author":"Khaled","year":"2016","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.prp.2017.06.017_bib0010","doi-asserted-by":"crossref","first-page":"pii: E33","DOI":"10.3390\/jcm5030033","article-title":"Acute myeloid leukemia: a concise review","volume":"5","author":"Saultz","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.prp.2017.06.017_bib0015","first-page":"317","article-title":"Novel prognostic and therapeutic mutations in acute myeloid leukemia","volume":"13","author":"Medinger","year":"2016","journal-title":"Cancer Genomics Proteomics"},{"issue":"Suppl","key":"10.1016\/j.prp.2017.06.017_bib0020","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.clml.2016.02.007","article-title":"Acute myeloid leukemia: past, present, and prospects for the future","volume":"16","author":"Short","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.prp.2017.06.017_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","article-title":"Molecular biomarkers in acute myeloid leukemia","volume":"31","author":"Prada-Arismendy","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.prp.2017.06.017_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dnarep.2016.09.003","article-title":"DNA damage response regulation by microRNAs as a therapeutic target in cancer","volume":"47","author":"Majidinia","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.prp.2017.06.017_bib0035","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00204-016-1828-2","article-title":"Recent progress toward the use of circulating microRNAs as clinical biomarkers","volume":"90","author":"Ghai","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.prp.2017.06.017_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","article-title":"Exploring miRNA based approaches in cancer diagnostics and therapeutics","volume":"98","author":"Mishra","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.prp.2017.06.017_bib0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/2395-3977.151470","article-title":"MicroRNAs are related to rituximab in combination with cyclophosphamide, doxorubicin vincristine, and prednisone resistance in patients with diffuse large B-cell lymphoma","volume":"1","author":"Huang","year":"2015","journal-title":"Cancer Transl. Med."},{"key":"10.1016\/j.prp.2017.06.017_bib0050","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ddr.21273","article-title":"Therapeutic targeting of microRNAs in cancer: future perspectives","volume":"76","author":"Tutar","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.prp.2017.06.017_bib0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00432-015-1995-1","article-title":"miR-181a promotes G1\/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM","volume":"142","author":"Liu","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.prp.2017.06.017_bib0060","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.3892\/mmr.2015.4455","article-title":"MicroRNA-519 enhances HL60 human acute myeloid leukemia cell line proliferation by reducing the expression level of RNA-binding protein human antigen R","volume":"12","author":"Huang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2017.06.017_bib0065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1746-1596-9-76","article-title":"Prognostic value of miR-96 in patients with acute myeloid leukemia","volume":"9","author":"Zhao","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2017.06.017_bib0070","first-page":"4841","article-title":"Overexpressed miR-155 is associated with initial presentation and poor outcome in Chinese pediatric acute myeloid leukemia","volume":"19","author":"Xu","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.prp.2017.06.017_bib0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clinbiochem.2012.09.002","article-title":"Prognostic value of miR-29a expression in pediatric acute myeloid leukemia","volume":"46","author":"Zhu","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.prp.2017.06.017_bib0080","doi-asserted-by":"crossref","first-page":"33816","DOI":"10.1038\/srep33816","article-title":"MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin","volume":"6","author":"Yen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2017.06.017_bib0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11033-014-3793-2","article-title":"The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer","volume":"42","author":"Erg\u00fcn","year":"2015","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.prp.2017.06.017_bib0090","first-page":"3175","article-title":"miR-122 inhibits metastasis and epithelial-mesenchymal transition of non-small-cell lung cancer cells","volume":"8","author":"Qin","year":"2015","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.prp.2017.06.017_bib0095","doi-asserted-by":"crossref","first-page":"59402","DOI":"10.18632\/oncotarget.10681","article-title":"Novel miR-122 delivery system based on MS2 virus like particle surface displaying cell-penetrating peptide TAT for hepatocellular carcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2017.06.017_bib0100","article-title":"miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma","author":"Lu","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2017.06.017_bib0105","first-page":"3056","article-title":"MiR-122 targets VEGFC in bladder cancer to inhibit tumor growth and angiogenesis","volume":"8","author":"Wang","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2017.06.017_bib0110","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.prp.2017.06.017_bib0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/ped.12865","article-title":"Acute myeloid leukemia in children: current status and future directions","volume":"58","author":"Taga","year":"2016","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.prp.2017.06.017_bib0120","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1007\/s13277-014-2089-4","article-title":"MiR-122\/Wnt\/\u03b2-catenin regulatory circuitry sustains glioma progression","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2017.06.017_bib0125","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.clinbiochem.2015.06.019","article-title":"High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation","volume":"48","author":"Cho","year":"2015","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.prp.2017.06.017_bib0130","doi-asserted-by":"crossref","first-page":"e79655","DOI":"10.1371\/journal.pone.0079655","article-title":"miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3","volume":"8","author":"Nassirpour","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2017.06.017_bib0135","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1007\/s13277-015-3128-5","article-title":"High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients","volume":"36","author":"Xu","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.prp.2017.06.017_bib0140","doi-asserted-by":"crossref","first-page":"e47053","DOI":"10.1371\/journal.pone.0047053","article-title":"MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817300122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033817300122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T09:00:54Z","timestamp":1535706054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033817300122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0344033817300122"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2017.06.017","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased expression of microRNA-122 is associated with an unfavorable prognosis in childhood acute myeloid leukemia and function analysis indicates a therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2017.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}